Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-13
2008-10-21
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S218000, C544S395000, C540S575000
Reexamination Certificate
active
07439245
ABSTRACT:
Disclosed is a method for use of phenyl sulfone compounds of formula (I) in the treatment of anxiety.
REFERENCES:
patent: 5627077 (1997-05-01), Dyllick-Brenzinger et al.
patent: 5665739 (1997-09-01), Lang et al.
patent: 5726177 (1998-03-01), Halazy et al.
patent: 0930302 (2003-04-01), None
patent: WO99/02502 (1999-01-01), None
patent: WO99/37623 (1999-07-01), None
patent: WO03/014097 (2003-02-01), None
Glennon et al. J. Med.Chem., vol. 43,p. 1011-1018 (2000).
Bentley et al.British Journal of Pharmacology Supplement, vol. 126, p. 66 (1999).
Bentley et al.Journal of Psychopharmacology Supplement, vol. A64, p. 255 (1997).
Bromidge et al.,Bioorganic&Medicinal Chemistry Letter, vol. 11(1), pp. 55-58 (2001).
Robichaud et al.,Annual Reports in Medicinal Chemistry, vol. 35, pp. 11-20 (2000).
Rogers et al.,Psychopharmacology, vol. 158, pp. 114-119 (2001).
Wesolowska et al.,Neuropharmacology, vol. 52, pp. 1274-1283 (2007).
MacDonald Gregor James
Thompson Mervyn
Bernhardt Emily
Fitch Duke M.
Glaxo Group Limited
Kinzig Charles M.
Sieburth Kathryn L.
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4008777